Magnifying endoscopy with narrow-band imaging helps determine the management of gastric adenomas
Open Access
- 18 January 2012
- journal article
- clinical trial
- Published by Springer Nature in Gastric Cancer
- Vol. 15 (4) , 414-418
Abstract
There are no clear clinical criteria for the management of gastric lesions diagnosed as adenomas (Vienna classification category 3) by pre-treatment biopsy. In the present study, we examined the feasibility of magnifying endoscopy with narrow-band imaging (ME–NBI) in discriminating early gastric cancers (Vienna classification category 4 or 5) from adenomas in lesions diagnosed as adenomas by pre-treatment biopsy.Keywords
This publication has 22 references indexed in Scilit:
- Japanese gastric cancer treatment guidelines 2010 (ver. 3)Gastric Cancer, 2011
- Is endoscopic forceps biopsy enough for a definitive diagnosis of gastric epithelial neoplasia?Journal of Gastroenterology and Hepatology, 2010
- The management of gastric polypsGut, 2010
- Histologic diagnosis based on forceps biopsy is not adequate for determining endoscopic treatment of gastric adenomatous lesionsEndoscopy, 2010
- The usefulness of magnifying endoscopy with narrow-band imaging to distinguish carcinoma in flat elevated lesions in the stomach diagnosed as adenoma by using biopsy samplesGastrointestinal Endoscopy, 2010
- Endoscopic characteristics of gastric adenomas suggesting carcinomatous transformationSurgical Endoscopy, 2008
- Clinical and Endoscopic Characterization of Depressed Gastric AdenomaEndoscopy, 2006
- Elevated risk for gastric adenocarcinoma can be predicted from histomorphologyWorld Journal of Gastroenterology, 2006
- Risk Factors Suggesting Malignant Transformation of Gastric Adenoma: Univariate and Multivariate AnalysisEndoscopy, 2001
- The Vienna classification of gastrointestinal epithelial neoplasiaGut, 2000